Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology Convergence 2022 Pharmaceutical Investing
The Gummy Project Announces Plans to Launch 3rd Endangered 'Keystone' Species Gummy Product - Coconut Flavoured Palm Trees Life Science Investing
Cybin Achieves Research and Development Milestones Ahead of Projected Timelines Life Science Investing
Aurinia Announces European Commission Approval of LUPKYNIS® for the Treatment of Lupus Nephritis Pharmaceutical Investing
AbbVie Secures Positive CHMP Opinion for Risankizumab for the Treatment of Adults with Moderate to Severe Crohn's Disease Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for LAG-3-Blocking Antibody Combination, Opdualag , for the Treatment of Unresectable or Metastatic Melanoma with Tumor Cell PD-L1 Expression < 1% Pharmaceutical Investing
Kite's CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Pharmaceutical Investing
CHMP Adopts Positive Opinion to Extend Indication of Veklury® for the Treatment of Pediatric Patients with COVID-19 Pharmaceutical Investing
WHO Expands Recommendation for Veklury® to Patients With Severe Disease in Latest Update to COVID-19 Guideline Pharmaceutical Investing
The Gummy Project Receives Purchaser Order from 5-Star Luxury Resort and Casino Located on the Las Vegas Strip Life Science Investing
